# OrthoPulse 2.0 and 2.1 Feasibility Evaluation

> **NCT03683017** · NA · UNKNOWN · sponsor: **Biolux Research Holdings, Inc.** · enrollment: 35 (actual)

## Conditions studied

- Malocclusion

## Interventions

- **DEVICE:** OrthoPulse 2.0
- **DEVICE:** OrthoPulse 2.1
- **DEVICE:** Invisalign 3.5 Day Wear
- **DEVICE:** Fixed Orthodontic Appliances (Braces)

## Key facts

- **NCT ID:** NCT03683017
- **Lead sponsor:** Biolux Research Holdings, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-22
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683017, "OrthoPulse 2.0 and 2.1 Feasibility Evaluation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03683017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*